Novartis-Intas Ranibizumab Case Set For Compromise?
This article was originally published in Scrip
Executive Summary
The Novartis-Intas wrangle over ranibizumab in India appears headed for a thaw, with both sides understood to be agreeable to an out-of-court settlement.